Senate Health panel floats proposal for speedy FDA approval of life-saving drugs

The draft includes legislation introduced last week by Sen. Michael BennetMichael Farrand BennetOVERNIGHT ENERGY: House Democrats tee up vote on climate-focused energy bill next week | EPA reappoints controversial leader to air quality advisory committee | Coronavirus creates delay in Pentagon research for alternative to 'forever chemicals' Senate Democrats demand White House fire controversial head of public lands agency Next crisis, keep people working and give them raises MORE (D-Colo.) that would expedite FDA approval and provide more flexibility when a drug or treatment shows dramatic responses early in development.


"We're seeing major breakthroughs in drugs and other treatments for debilitating and terminal diseases, but we're not always getting them to patients though the most efficient and safe pathways," Bennet said in a statement Wednesday. "This bipartisan plan is a good starting point to ensure patients have access to safe, innovative treatments as quickly as possible."

The proposal would become part of legislation to reauthorize user fee legislation, which expires Sept. 30.